Fundraising Fox
/Companies
Sign in

Enumera Molecular

Ann Arbor, US · Founded 2022 · Delaware corporation · 16 employees on LinkedIn · 3 known investors

Find your way into Enumera Molecular

Sign up to see every warm intro you have to Enumera Molecular

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Enumera Molecular team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Enumera Molecular develops technology and a platform for simplified, lower-cost workflows that enable liquid biopsy and high-dimensional omics assays for laboratories. It targets clinical labs performing molecular diagnostics.

BiotechDeep TechHealthtechMedical Devices

Founders & leadership

Enumera Molecular was founded in 2022 by Matthew Cooper.

MCMatthew Cooper
Matthew CooperFounder · Chief Executive OfficerMatthew Cooper holds a Ph.D. in Toxicology from the University of Kentucky and dual MBAs from Columbia Business School and UC Berkeley Haas School of Business. He has over 20 years of experience in diagnostic and data science product development, with expertise in biomarker discovery, bioinformatics, and drug development, and previously founded multiple biotech and diagnostic companies.
EH
Elaine HeronNamed on SEC filing

Board

DKDan Kidle
Dan KidleBoard MemberManaging Partner at Arboretum Ventures
SB
Sundaresh BrahmasandraBoard director

Investors · 3

Sand Hill Angelslisted by Sand Hill AngelsMenlo Park · $50K – $2M

How we know: sandhillangels.com · Not right? Tell us

StartXlisted by StartXStanford · $10K – $1M

How we know: StartX's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$31M disclosed across 2 rounds · 2022–2026

▶$12.3MraisedJul 2026 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew CooperExecutive Officer, Director
  • Dan KidleDirector
  • Elaine HeronDirector
  • Sundaresh BrahmasandraDirector
Offering amount
$17.4M
Amount sold
$12.3M
First sale
Jul 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$18.7MraisedAug 2022 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew CooperExecutive Officer, Director
Offering amount
$19M
Amount sold
$18.7M
First sale
May 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

IDbyDNAScalable, high throughput DNA sequencing platforms.
GenomenonGenomenon uses AI to read biomedical literature and expert scientists to curate variant- and patient-level genomic evidence, delivering regulatory-grade real-world evidence. Its products, including Mastermind and CKB, serve drug development teams and clinical genetic testing labs for variant interpretation and drug program decisions.
InvitaeInvitae provides genetic testing services to patients and clinicians across the United States, offering broad test offerings and genetic counseling to inform health decisions at every stage of life. Now part of Labcorp, the company leverages a nationwide network of patient service centers and coverage by most health plans to make genetic testing more accessible.

Companies working in the same space as Enumera Molecular.

Frequently asked questions

What does Enumera Molecular do?
Enumera Molecular develops technology and a platform for simplified, lower-cost workflows that enable liquid biopsy and high-dimensional omics assays for laboratories. It targets clinical labs performing molecular diagnostics.
Who founded Enumera Molecular?
Enumera Molecular was founded by Matthew Cooper in 2022.
Who are Enumera Molecular's investors?
Enumera Molecular's investors include Arboretum Ventures, Sand Hill Angels, StartX.
How much funding has Enumera Molecular raised?
Enumera Molecular has disclosed $31M raised across 2 rounds.
Where is Enumera Molecular headquartered?
Enumera Molecular is headquartered in Ann Arbor, US.